What does a Bleeding Time Clotting Test (BT CT) indicate in a patient with a snake bite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bleeding Time Clotting Test (BT CT) in Snake Bite

The 20-minute Whole Blood Clotting Test (WBCT20) is a critical bedside diagnostic tool that detects venom-induced consumption coagulopathy (VICC) in snake bite patients, with a sensitivity of 82-94% and specificity of 76-98%, and should be performed immediately upon presentation to guide antivenom administration decisions. 1, 2

What the Test Indicates

The WBCT20 directly assesses whether snake venom has caused consumption coagulopathy by observing whether whole blood forms a clot within 20 minutes. 3, 1

  • Positive test (no clot formation at 20 minutes): Indicates venom-induced consumption coagulopathy requiring antivenom administration 1, 2
  • Negative test (normal clot formation): Suggests intact coagulation, though does NOT completely rule out envenomation 1, 2

Clinical Performance Characteristics

The test demonstrates robust diagnostic utility when performed correctly:

  • Sensitivity ranges from 82-94%, meaning it correctly identifies most patients with coagulopathy but misses approximately 6-18% of cases 1, 2
  • Specificity ranges from 76-98%, with false positive rates of 2-24% depending on the study population 1, 2
  • The test is most reliable for pit viper envenomations (rattlesnakes, copperheads, cottonmouths) which cause cytotoxic effects including coagulopathy 4

Critical Testing Protocol

Proper technique is essential for accuracy:

  • Use exactly 1 mL of fresh whole blood in a clean, dry 5 mL borosilicate glass tube with 10 mm internal diameter 1
  • Perform the test at bedside immediately upon patient arrival 3, 5
  • Read results at BOTH 20 and 30 minutes for enhanced sensitivity—discrepancies between readings occur in 82% of coagulopathic patients and improve detection of evolving or resolving coagulopathy 6
  • Alternative containers (syringe or ceftriaxone bottle) show 84.7-86.8% accuracy when laboratory testing is unavailable 5

Clinical Decision-Making Algorithm

For patients with positive WBCT20 AND clinical signs of envenomation (swelling, pain, ecchymosis, hypotension):

  • Administer antivenom immediately—this is the definitive treatment 4, 7

For asymptomatic patients with positive WBCT20 but NO clinical signs:

  • Confirm with PT/INR (cutoff ≥1.4) before administering antivenom to avoid unnecessary treatment, as false positive rate can reach 24% 2

For patients with negative WBCT20:

  • Do NOT assume no envenomation—the test misses up to 18% of coagulopathy cases 1
  • Continue clinical monitoring for at least 12-24 hours, as neurotoxic symptoms can be delayed up to 13 hours despite minimal local findings 8
  • Repeat WBCT20 at 4 and 12 hours to detect delayed coagulopathy 2

Serial Monitoring Strategy

After antivenom administration:

  • Repeat WBCT20 at both 20 and 30 minutes every 4-6 hours to monitor treatment response 6
  • Discrepancies between 20 and 30-minute readings most commonly occur during three critical phases: initial normalization after antivenom, detection of secondary coagulopathy resumption, or final restoration of hemostasis 6
  • A positive test after initial normalization indicates need for additional antivenom doses 6, 2

Critical Pitfalls to Avoid

Never delay antivenom administration in clinically evident envenomation while waiting for WBCT20 results—the test guides therapy but should not delay life-saving treatment when clinical signs are obvious 4

Do not rely on WBCT20 alone for coral snake bites—these neurotoxic envenomations cause minimal tissue injury and coagulopathy, requiring different monitoring for respiratory compromise 4, 8

Avoid using WBCT20 as the sole criterion for antivenom in asymptomatic patients—confirm with PT/INR to prevent unnecessary antivenom administration given the 24% false positive rate 2

Practical Advantages

The WBCT20 is particularly valuable in resource-limited settings:

  • Requires only a clean glass tube and venous blood—no laboratory equipment needed 3, 5
  • Results available within 20-30 minutes at bedside 3, 1
  • Inexpensive and deployable in isolated hospitals where 95% of snakebites occur 3, 6
  • Demonstrates excellent inter-observer reliability with no significant variability between trained observers 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bedside whole-blood clotting times: validity after snakebites.

The Journal of emergency medicine, 2013

Guideline

Snakebite Management in Emergency Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Neurotoxic Snake Bite Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.